ZOMETA® Patient Case Study: Breast Cancer Medical Profile – Diagnosis And Treatment

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA Patient Case Study: Breast Cancer

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

ZOMETA® Breast Cancer Patient Case Study - Marta

Marta N.

Aged 57 years
Math teacher
Grandmother of 2

Page

1 2 3

Diagnosis and treatment of bone metastases

Marta presented 6 months ago with a 1-month history of pain in the left thigh
Bone scan confirmed metastases in the left femur and left ischium
No evidence of metastasis to other organs
Immediately after her diagnosis, Marta began treatment with
- — Chemotherapy: docetaxel every 3 weeks + capecitabine BID
- — Aromatase inhibitor therapy: daily letrozole
- — ZOMETA® every 3 weeks
Marta is currently symptom free

Page

1 2 3

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.